kifunensine has been researched along with Protein Folding Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abel, L; Aksu, G; Blancas-Galicia, L; Bogunovic, D; Boisson, B; Boisson-Dupuis, S; Bryant, VL; Bustamante, J; Casanova, JL; Espinosa-Padilla, S; Espinosa-Rosales, F; Franco, JL; Itan, Y; Kong, XF; Kreins, AY; Kutukculer, N; Martinez-Barricarte, R; Migaud, M; Moncada-Vélez, M; Okada, S; Ramírez-Alejo, N; Tirpan, C; Vincent, QB; Vogt, G; Yamazaki-Nakashimada, M | 1 |
| Brancati, G; Segatori, L; Song, W; Wang, F | 1 |
2 other study(ies) available for kifunensine and Protein Folding Diseases
| Article | Year |
|---|---|
Partial IFN-γR2 deficiency is due to protein misfolding and can be rescued by inhibitors of glycosylation.
Topics: Alkaloids; Base Sequence; Blotting, Western; Child; Enzyme Inhibitors; Female; Flow Cytometry; Genetic Predisposition to Disease; Glycosylation; Humans; Male; Microscopy, Confocal; Molecular Sequence Data; Mutation; Mycobacterium Infections; Pedigree; Proteostasis Deficiencies; Receptors, Interferon; Transfection | 2013 |
Inhibition of endoplasmic reticulum-associated degradation rescues native folding in loss of function protein misfolding diseases.
Topics: Alkaloids; Apoptosis; Blotting, Western; Cells, Cultured; Endoplasmic Reticulum-Associated Degradation; Humans; Hydrazones; Hydroxyurea; Lysosomal Storage Diseases; Molecular Chaperones; Protein Folding; Proteostasis Deficiencies; Real-Time Polymerase Chain Reaction; Unfolded Protein Response | 2011 |